Patent Yard Sign in
Australian application, no grantAustralia

N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production

AU 2000040024 · Applicant: Fibrogen Inc

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 18, 2000. Even if it was granted, its term would have ended by February 18, 2021.
  • A pharmaceutical extension adds at most five years, so even that would have ended by February 18, 2026.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 18, 2000
GrantedNo grant recorded
Term ended byFebruary 18, 2021
Application numberAU 2000040024
Classification (IPC)C07C311/06 +2 more

Timeline

Timeline From IP Australia dates

2001200420072010201320162019Application filedFeb 18, 2000Term ended byFeb 18, 2021

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.